Glenn Goddard

Glenn Goddard is a seasoned financial executive with extensive experience in the biotechnology sector. Since March 2025, Glenn has served as Chief Financial Officer at Auron Therapeutics, Inc. Previously, Glenn was the Chief Financial Officer at Intellia Therapeutics, Inc. from October 2018 to June 2024, and prior to that, held the same title at Generation Bio from May 2017 to October 2018. Additionally, Glenn contributed to AvenCell as a Board Member and Audit Committee Chair from November 2021 to June 2024. Earlier in their career, Glenn was the Senior Vice President Finance and Principal Financial Officer at Agios from July 2010 to November 2016. Glenn's professional background includes expertise in fundraising and investor relations, supported by a degree from Bentley University earned between January 1990 and January 1994.